recombinant mpo Search Results


active recombinant mouse mpo  (Creative BioMart)
93
Creative BioMart active recombinant mouse mpo
( A ) Schematic of splenocyte transfer model. ( B – E ) Splenocytes from <t>MPO</t> –/– mice immunized with <t>recombinant</t> mouse MPO (rmMPO) ( B , n = 3) or HA-rmMPO ( D , n = 3) caused glomerulonephritis, indicated by crescent formation (arrow) (scale bar: 20 μm). Splenocytes from WT mice immunized with rmMPO ( C , n = 3) or HA-rmMPO ( E , n = 3) did not cause glomerulonephritis in Rag2-knockout mice after transfer. ( F ) Quantification of glomerular crescents. ( G ) Quantification of glomerular necrosis. Data are expressed as mean ± SEM. Graph was drawn using GraphPad Prism (GraphPad Software, Version 9.5.1). *** P < 0.001; **** P < 0.0001 assessed by 1-way ANOVA with multiple comparisons.
Active Recombinant Mouse Mpo, supplied by Creative BioMart, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mpo/Recombinant+Mouse+MPO+Protein/pmc11996859-216-0-9
Average 93 stars, based on 1 article reviews
active recombinant mouse mpo - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
recombinant myeloperoxidase protein  (ABclonal Biotechnology)
93
ABclonal Biotechnology recombinant myeloperoxidase protein
( A ) Schematic of splenocyte transfer model. ( B – E ) Splenocytes from <t>MPO</t> –/– mice immunized with <t>recombinant</t> mouse MPO (rmMPO) ( B , n = 3) or HA-rmMPO ( D , n = 3) caused glomerulonephritis, indicated by crescent formation (arrow) (scale bar: 20 μm). Splenocytes from WT mice immunized with rmMPO ( C , n = 3) or HA-rmMPO ( E , n = 3) did not cause glomerulonephritis in Rag2-knockout mice after transfer. ( F ) Quantification of glomerular crescents. ( G ) Quantification of glomerular necrosis. Data are expressed as mean ± SEM. Graph was drawn using GraphPad Prism (GraphPad Software, Version 9.5.1). *** P < 0.001; **** P < 0.0001 assessed by 1-way ANOVA with multiple comparisons.
Recombinant Myeloperoxidase Protein, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mpo/Recombinant+Human+MPO+Protein/pm40532643-59-41-44
Average 93 stars, based on 1 article reviews
recombinant myeloperoxidase protein - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
recombinant human mpo  (Creative BioMart)
85
Creative BioMart recombinant human mpo
( A ) Schematic of splenocyte transfer model. ( B – E ) Splenocytes from <t>MPO</t> –/– mice immunized with <t>recombinant</t> mouse MPO (rmMPO) ( B , n = 3) or HA-rmMPO ( D , n = 3) caused glomerulonephritis, indicated by crescent formation (arrow) (scale bar: 20 μm). Splenocytes from WT mice immunized with rmMPO ( C , n = 3) or HA-rmMPO ( E , n = 3) did not cause glomerulonephritis in Rag2-knockout mice after transfer. ( F ) Quantification of glomerular crescents. ( G ) Quantification of glomerular necrosis. Data are expressed as mean ± SEM. Graph was drawn using GraphPad Prism (GraphPad Software, Version 9.5.1). *** P < 0.001; **** P < 0.0001 assessed by 1-way ANOVA with multiple comparisons.
Recombinant Human Mpo, supplied by Creative BioMart, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mpo/Recombinant+Human+Myeloperoxidase/pmc04005303-236-0-10
Average 85 stars, based on 1 article reviews
recombinant human mpo - by Bioz Stars, 2026-10
85/100 stars
  Buy from Supplier
recombinant myeloperoxidase mpo  (R&D Systems)
90
R&D Systems recombinant myeloperoxidase mpo
Fig. 4. Impairment of cholesterol uptake ca- pacity by the <t>MPO-mediated</t> oxidation of HDL. (A), apoB-depleted serum or <t>recombinant</t> (Rec) apoA1 was oxidized by 100 nmol/L MPO–40 μmol/L H2O2–200 μmol/L NO2 −and analyzed by Western blotting. (B and C), The cholesterol efflux capacity (B) and uptake capacity (C) of apoB-depleted serum modified by MPO–H2O2–NO2 −
Recombinant Myeloperoxidase Mpo, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mpo/Myeloperoxidase%2FMPO+Recombinant+Protein+Antigen/pm32630971-56-0-6
Average 90 stars, based on 1 article reviews
recombinant myeloperoxidase mpo - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
recombinant human mpo  (US Biological Life Sciences)
90
US Biological Life Sciences recombinant human mpo
Effects of NET components <t>MPO</t> and histone 3 on the proliferation and differentiation of LF. LFs were divided into control, PMA, PMA+MPO inhibitor, PMA+H3 inhibitor, blank, <t>rhMPO</t> and rhH3 groups. A, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET decreased mRNA levels of ACTA2, CCN2 and ADAM12 in LFs. B, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET down‐regulated protein levels of α‐SMA and CCN2 in LFs. C, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET reduced collagen production of LFs. D, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET suppressed the proliferation of LFs, whereas rhMPO and rhH3 promoted mRNA levels of ACTA2, CCN2 and ADAM12, protein levels of α‐SMA and CCN2, collagen production and proliferation of LFs. ** P < .01 vs control, ## P < .01 vs PMA, && P < .01 vs blank
Recombinant Human Mpo, supplied by US Biological Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mpo/recombinant+human+mpo/pmc06991674-79-5-8
Average 90 stars, based on 1 article reviews
recombinant human mpo - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
recombinant human myeloperoxidase protein, cf  (Bio-Techne corporation)
94
Bio-Techne corporation recombinant human myeloperoxidase protein, cf
Effects of NET components <t>MPO</t> and histone 3 on the proliferation and differentiation of LF. LFs were divided into control, PMA, PMA+MPO inhibitor, PMA+H3 inhibitor, blank, <t>rhMPO</t> and rhH3 groups. A, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET decreased mRNA levels of ACTA2, CCN2 and ADAM12 in LFs. B, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET down‐regulated protein levels of α‐SMA and CCN2 in LFs. C, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET reduced collagen production of LFs. D, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET suppressed the proliferation of LFs, whereas rhMPO and rhH3 promoted mRNA levels of ACTA2, CCN2 and ADAM12, protein levels of α‐SMA and CCN2, collagen production and proliferation of LFs. ** P < .01 vs control, ## P < .01 vs PMA, && P < .01 vs blank
Recombinant Human Myeloperoxidase Protein, Cf, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mpo/Recombinant+Human+Myeloperoxidase+Protein%2C+CF/bio-techne+corporation___3174-mp
Average 94 stars, based on 1 article reviews
recombinant human myeloperoxidase protein, cf - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
recombinant human mpo, gst-tagged  (Creative BioMart)
N/A
Recombinant fragment with GST tag corresponding to amino acids 621-745 of Human Myeloperoxidase; 125 amino acids, 40kDa.Myeloperoxidase (MPO) is a heme protein synthesized during myeloid differentiation that constitutes the major component of neutrophil azurophilic granules.
   Buy from Supplier
recombinant human myeloperoxidase/mpo  (Beijing Solarbio Science)
N/A
   Buy from Supplier
myeloperoxidase/mpo recombinant protein antigen  (Novus Biologicals)
N/A
Myeloperoxidase/MPO Recombinant Protein Antigen
   Buy from Supplier
mpo nm 010824 mouse recombinant protein  (OriGene)
N/A
Purified recombinant protein of Mouse myeloperoxidase Mpo with C terminal MYC DDK tag expressed in HEK293T cells 20ug
   Buy from Supplier
myeloperoxidase mpo nm 000250 human recombinant protein  (OriGene)
N/A
Recombinant protein of human myeloperoxidase MPO nuclear gene encoding mitochondrial protein
   Buy from Supplier

Image Search Results


( A ) Schematic of splenocyte transfer model. ( B – E ) Splenocytes from MPO –/– mice immunized with recombinant mouse MPO (rmMPO) ( B , n = 3) or HA-rmMPO ( D , n = 3) caused glomerulonephritis, indicated by crescent formation (arrow) (scale bar: 20 μm). Splenocytes from WT mice immunized with rmMPO ( C , n = 3) or HA-rmMPO ( E , n = 3) did not cause glomerulonephritis in Rag2-knockout mice after transfer. ( F ) Quantification of glomerular crescents. ( G ) Quantification of glomerular necrosis. Data are expressed as mean ± SEM. Graph was drawn using GraphPad Prism (GraphPad Software, Version 9.5.1). *** P < 0.001; **** P < 0.0001 assessed by 1-way ANOVA with multiple comparisons.

Journal: The Journal of Clinical Investigation

Article Title: Sequential carbonyl derivatives and hydrazone adduct formation on myeloperoxidase contribute to development of ANCA vasculitis

doi: 10.1172/JCI178813

Figure Lengend Snippet: ( A ) Schematic of splenocyte transfer model. ( B – E ) Splenocytes from MPO –/– mice immunized with recombinant mouse MPO (rmMPO) ( B , n = 3) or HA-rmMPO ( D , n = 3) caused glomerulonephritis, indicated by crescent formation (arrow) (scale bar: 20 μm). Splenocytes from WT mice immunized with rmMPO ( C , n = 3) or HA-rmMPO ( E , n = 3) did not cause glomerulonephritis in Rag2-knockout mice after transfer. ( F ) Quantification of glomerular crescents. ( G ) Quantification of glomerular necrosis. Data are expressed as mean ± SEM. Graph was drawn using GraphPad Prism (GraphPad Software, Version 9.5.1). *** P < 0.001; **** P < 0.0001 assessed by 1-way ANOVA with multiple comparisons.

Article Snippet: Active recombinant mouse MPO (Cat MPO-428M) was purchased from Creative BioMart Inc.

Techniques: Recombinant, Knock-Out, Software

Fig. 4. Impairment of cholesterol uptake ca- pacity by the MPO-mediated oxidation of HDL. (A), apoB-depleted serum or recombinant (Rec) apoA1 was oxidized by 100 nmol/L MPO–40 μmol/L H2O2–200 μmol/L NO2 −and analyzed by Western blotting. (B and C), The cholesterol efflux capacity (B) and uptake capacity (C) of apoB-depleted serum modified by MPO–H2O2–NO2 −

Journal: The journal of applied laboratory medicine

Article Title: Cholesterol Uptake Capacity: A New Measure of HDL Functionality for Coronary Risk Assessment.

doi: 10.1373/jalm.2016.022913

Figure Lengend Snippet: Fig. 4. Impairment of cholesterol uptake ca- pacity by the MPO-mediated oxidation of HDL. (A), apoB-depleted serum or recombinant (Rec) apoA1 was oxidized by 100 nmol/L MPO–40 μmol/L H2O2–200 μmol/L NO2 −and analyzed by Western blotting. (B and C), The cholesterol efflux capacity (B) and uptake capacity (C) of apoB-depleted serum modified by MPO–H2O2–NO2 −

Article Snippet: Recombinant myeloperoxidase (MPO) was purchased from R&D Systems.

Techniques: Recombinant, Western Blot

Effects of NET components MPO and histone 3 on the proliferation and differentiation of LF. LFs were divided into control, PMA, PMA+MPO inhibitor, PMA+H3 inhibitor, blank, rhMPO and rhH3 groups. A, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET decreased mRNA levels of ACTA2, CCN2 and ADAM12 in LFs. B, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET down‐regulated protein levels of α‐SMA and CCN2 in LFs. C, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET reduced collagen production of LFs. D, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET suppressed the proliferation of LFs, whereas rhMPO and rhH3 promoted mRNA levels of ACTA2, CCN2 and ADAM12, protein levels of α‐SMA and CCN2, collagen production and proliferation of LFs. ** P < .01 vs control, ## P < .01 vs PMA, && P < .01 vs blank

Journal: Journal of Cellular and Molecular Medicine

Article Title: Neutrophil extracellular traps activate lung fibroblast to induce polymyositis‐related interstitial lung diseases via TLR9‐miR‐7‐Smad2 pathway

doi: 10.1111/jcmm.14858

Figure Lengend Snippet: Effects of NET components MPO and histone 3 on the proliferation and differentiation of LF. LFs were divided into control, PMA, PMA+MPO inhibitor, PMA+H3 inhibitor, blank, rhMPO and rhH3 groups. A, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET decreased mRNA levels of ACTA2, CCN2 and ADAM12 in LFs. B, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET down‐regulated protein levels of α‐SMA and CCN2 in LFs. C, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET reduced collagen production of LFs. D, Compared with PMA group, MPO inhibitor or H3 inhibitor‐treated NET suppressed the proliferation of LFs, whereas rhMPO and rhH3 promoted mRNA levels of ACTA2, CCN2 and ADAM12, protein levels of α‐SMA and CCN2, collagen production and proliferation of LFs. ** P < .01 vs control, ## P < .01 vs PMA, && P < .01 vs blank

Article Snippet: In rhMPO group, 10 ng/mL recombinant human MPO (USBiological) was used to stimulate LFs.

Techniques: Control